Sangamo Therapeutics, Inc.
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases

Abstract:

Disclosed herein are methods and compositions for modifying TCR genes, using nucleases (zinc finger nucleases or TAL nucleases) to modify TCR genes.